Metropolitan Life Insurance Company (MetLife)’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,004
Closed -$4.8K 2546
2023
Q1
$4.8K Sell
4,004
-637
-14% -$1.42K ﹤0.01% 2273
2022
Q4
$6.59K Buy
4,641
+70
+2% +$150 ﹤0.01% 2348
2022
Q3
$11.2K Buy
+4,571
New +$15.3K ﹤0.01% 2267
2022
Q2
Sell
-4,566
Closed -$30.7K 2461
2022
Q1
$30.7K Sell
4,566
-13,987
-75% -$120K ﹤0.01% 1871
2021
Q4
$168K Buy
18,553
+851
+5% +$7.91K ﹤0.01% 2146
2021
Q3
$179K Buy
17,702
+2,112
+14% +$23.2K ﹤0.01% 2162
2021
Q2
$200K Sell
15,590
-3,155
-17% -$43.3K ﹤0.01% 2142
2021
Q1
$265K Sell
18,745
-1,725
-8% -$23.8K ﹤0.01% 1823
2020
Q4
$218K Buy
20,470
+1,065
+5% +$9.67K ﹤0.01% 1880
2020
Q3
$148K Sell
19,405
-4,124
-18% -$30.3K ﹤0.01% 1968
2020
Q2
$143K Sell
23,529
-102
-0.4% -$503 ﹤0.01% 2036
2020
Q1
$83.2K Sell
23,631
-905
-4% -$7.66K ﹤0.01% 2151
2019
Q4
$259K Sell
24,536
-400
-2% -$3.55K ﹤0.01% 1742
2019
Q3
$279K Hold
24,936
﹤0.01% 1650
2019
Q2
$228K Hold
24,936
﹤0.01% 1813
2019
Q1
$276K Sell
24,936
-33
-0.1% -$231 0.01% 1686
2018
Q4
$62.2K Hold
24,969
﹤0.01% 2496
2018
Q3
$112K Hold
24,969
﹤0.01% 2379
2018
Q2
$298K Sell
24,969
-19,717
-44% -$264K ﹤0.01% 1669
2018
Q1
$688K Buy
44,686
+785
+2% +$13.1K 0.01% 1081
2017
Q4
$718K Sell
43,901
-76,256
-63% -$1.47M 0.01% 1061
2017
Q3
$2.75M Sell
120,157
-207
-0.2% -$4.41K 0.02% 838
2017
Q2
$3.37M Buy
120,364
+6,720
+6% +$186K 0.02% 776
2017
Q1
$3.49M Sell
113,644
-3,126
-3% -$88.3K 0.02% 755
2016
Q4
$2.94M Sell
116,770
-1,426
-1% -$33.6K 0.02% 823
2016
Q3
$2.93M Buy
118,196
+13,872
+13% +$368K 0.02% 811
2016
Q2
$2.59M Buy
104,324
+1,565
+2% +$40.3K 0.02% 848
2016
Q1
$2.97M Buy
102,759
+2,239
+2% +$58.5K 0.02% 752
2015
Q4
$3.02M Buy
100,520
+259
+0.3% +$8.8K 0.02% 730
2015
Q3
$2.98M Sell
100,261
-1,419
-1% -$46.1K 0.02% 741
2015
Q2
$3.56M Buy
101,680
+42,043
+70% +$1.48M 0.03% 717
2015
Q1
$2.12M Buy
59,637
+2,041
+4% +$68.8K 0.02% 884
2014
Q4
$2M Buy
57,596
+615
+1% +$21.7K 0.01% 974
2014
Q3
$2.01M Buy
56,981
+343
+0.6% +$12.9K 0.01% 947
2014
Q2
$2.27M Buy
56,638
+2,970
+6% +$114K 0.02% 948
2014
Q1
$2.14M Buy
53,668
+1,377
+3% +$49.6K 0.01% 956
2013
Q4
$1.73M Buy
52,291
+196
+0.4% +$6.11K 0.01% 1047
2013
Q3
$1.53M Buy
52,095
+861
+2% +$27K 0.01% 1065
2013
Q2
$1.73M Buy
+51,234
New +$1.59M 0.01% 964

Other funds holding DBD

Metropolitan Life Insurance Company (MetLife)'s DBD Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 4,004 shares — an estimated $4.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DBD in Q2 2013 and held it in 39 quarters. The position peaked at $3.56M in Q2 2015. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,004 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $4.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 39 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Diebold Nixdorf Incorporated position peaked at $3.56M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.